Inhibikase Therapeutics, Inc.IKTNASDAQ
Loading
Net Income ContractionContracting
Percentile Rank0
Studio
Year-over-Year Change

Total earnings after all expenses, taxes, and interest

Latest
$-47.66M
↓ 243% vs avg
Percentile
P0
Near historical low
Streak
5 yr
Consecutive declineContracting
Average
$-13.88M
Historical baseline
PeriodValueYoY Change
TTM$-47.66M-73.2%
2024$-27.52M-44.6%
2023$-19.03M-5.4%
2022$-18.05M-22.1%
2021$-14.79M-419.2%
2020$-2.85M+50.2%
2019$-5.72M-165.9%
2018$-2.15M-393.6%
2017$-436075.00+30.6%
2016$-628737.00-